Irbesartan
![Irbesartan Structure](CAS/GIF/138402-11-6.gif)
- CAS No.
- 138402-11-6
- Chemical Name:
- Irbesartan
- Synonyms
- AVAPRO;Lrbesartan;Irbesatan;Irbesartan Impurity 1;3-butyl-2-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diazaspiro[4.4]non-3-en-1-one;APROVEL;CS-1097;SR-47436;Irbesarta;BMS-186295
- CBNumber:
- CB4454663
- Molecular Formula:
- C25H28N6O
- Molecular Weight:
- 428.53
- MOL File:
- 138402-11-6.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/7/24 17:31:20
Melting point | 180-181°C |
---|---|
Boiling point | 648.6±65.0 °C(Predicted) |
Density | 1.30±0.1 g/cm3(Predicted) |
storage temp. | 2-8°C |
solubility | DMSO: >25mg/mL |
pka | 4.16±0.10(Predicted) |
form | powder |
color | white to off-white |
Merck | 14,5083 |
BCS Class | 2 |
CAS DataBase Reference | 138402-11-6(CAS DataBase Reference) |
EPA Substance Registry System | 1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (138402-11-6) |
Irbesartan price More Price(5)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich(India) | PHR1443 | Irbesartan Pharmaceutical Secondary Standard; Certified Reference Material | 138402-11-6 | 1G | ₹9103.83 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | I2286 | Irbesartan ≥98% (HPLC), powder | 138402-11-6 | 10MG | ₹9428.58 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | I2286 | Irbesartan ≥98% (HPLC), powder | 138402-11-6 | 50MG | ₹38017.4 | 2022-06-14 | Buy |
TCI Chemicals (India) | I0859 | Irbesartan | 138402-11-6 | 1G | ₹5500 | 2022-05-26 | Buy |
TCI Chemicals (India) | I0859 | Irbesartan | 138402-11-6 | 5G | ₹6900 | 2022-05-26 | Buy |
Irbesartan Chemical Properties,Uses,Production
Description
Avapro was launched in Germany, the UK and the US for hypertension. It can be prepared in six steps starting with cyclopentanone or in three steps from 1- aminocyclopentanecarboxylic acid ethyl ester and pentanimidic ethyl ester. Avapro is an angiotensin Ⅱ receptor antagonist that is non-competitive and selective for AT, subtypes and has no AT2 activity at postsynaptic receptors compared to presynatpic. It has no affinity for various non angiotensin Ⅱ receptor types in binding, no interaction with calcium channels or antiports, and no affinity for α1- and α2--adrenoreceptors, serotonergic receptors, muscarinic m1 and m2 or other receptors. It is as potent as saralasin but with no agonist activity and is 10 times more potent than DuP753 in rats. It is similar in efficacy to enalapril (in those with severe hypertension) and atenolol, while more effective than losartan for mild to moderate hypertension.
Chemical Properties
Crystalline Solid
Uses
For the treatment of hypertension, as well as diabetic nephropathy with an elevated serum creatinine and proteinuria (>300 mg/day) in patients with type 2 diabetes and hypertension. Irbesartan is also used as a second line agent in the treatment of conges
Definition
ChEBI: A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
General Description
Irbesartan, 2-butyl-3-[[29-(1H-tetrazol-5-yl)[1,19-biphenyl]-4-yl]methyl]1,3-diazaspiro[4,4]non-1en-4-one (Avapro), like losartan, possesses the acidic tetrazolesystem, which most likely plays a role, similar to the acidicgroups of angiotensin II, in binding to the angiotensin II receptor.In addition, the biphenyl system that serves to separatethe tetrazole from the aliphatic nitrogen is still present.A major difference in this agent is that it does not possessthe acidic side chain. Even so, irbesartan has good affinityfor the angiotensin II receptor because of hydrogen bondingwith the carbonyl moiety of the amide system. Also, thisparticular agent does not require metabolic activation ascandesartan does.
Irbesartan Preparation Products And Raw materials
Raw materials
1of4
chevron_rightPreparation Products
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
GLR Innovations | +91 9891111994 | New Delhi, India | 4542 | 58 | Inquiry |
Cadila Pharmaceuticals Ltd | +91-7069076657 +91-7069076657 | Ahmedabad, India | 54 | 58 | Inquiry |
ANWITA APIS | +919000311012 | Hyderabad, India | 198 | 58 | Inquiry |
Dr. Reddy's Laboratories Ltd | +91-4049002900 +91-4049002900 | Hyderabad, India | 165 | 58 | Inquiry |
Hetero Drugs Limited | +91-4023704923 +91-4023704923 | Telangana, India | 296 | 58 | Inquiry |
Macleods Pharmaceuticals Limited | +91-2266762800 +91-2266762800 | Maharashtra, India | 116 | 58 | Inquiry |
Divis Laboratories Ltd | +91-4066966413 +91-4066966413 | Hyderabad, India | 34 | 58 | Inquiry |
CTX Lifesciences Pvt Ltd | +91-2612399669 +91-7434851395 | Gujarat, India | 28 | 58 | Inquiry |
Sun Pharmaceutical Industries Ltd | +91-2242244224 +91-2243244324 | Maharashtra, India | 108 | 58 | Inquiry |
Unichem Laboratories Ltd | +91-2266888333 +91-2266888333 | Maharashtra, India | 62 | 58 | Inquiry |
138402-11-6(Irbesartan)Related Search:
1of4
chevron_right